1. Augustyns K.; Veken P. V.d.; Senten K.; Haemers A.
The Therapeutic Potential of Inhibitors of Dipeptidyl Peptidase IV (DPP IV) and Related Proline-Specific Dipeptidyl Aminopeptidases
Current Medicinal Chemistry, Bentham Science Publishers (IngentaConnect)
April 2005 , Volume 12, Number 8, pp. 971-998
- DOI:
http://dx.doi.org/10.2174/0929867053507298
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
Regulatory Peptides (SD)
15 June 2005, Volume 128, Issue 2, Pages 159-165
- DOI:
http://dx.doi.org/10.1016/j.regpep.2004.06.001
Synergistic Action of DPIV and APN in the Regulation of T Cell Function
Advances in Experimental Medicine and Biology (SpringerLink)
2003, Volume 524, Part 3, 123-131
- DOI:
http://dx.doi.org/10.1007/0-306-47920-6_16
Dipeptidyl Peptidase IV (CD26): Role in T Cell Activation and Autoimmune Disease
Advances in Experimental Medicine and Biology (SpringerLink)
2002, Volume 477, Part I, 155-160
- DOI:
http://dx.doi.org/10.1007/0-306-46826-3_17
5. D. Reinhold, T. Kähne, A. Steinbrecher, S. Wrenger, K. Neubert, S. Ansorge, S. Brocke
The Role of Dipeptidyl Peptidase IV (DP IV) Enzymatic Activity in T Cell Activation and Autoimmunity
Biological Chemistry (ReferenceGlobal)
July.-Aug. 2002, Volume 383, Issue 7-8, Pages 1133–1138
- DOI:
http://dx.doi.org/10.1515/BC.2002.123
Спасибо!